Delirium Market Research Report Information by Type (Hyperactive, Hypoactive, Mixed), By Diagnosis and treatment (Diagnosis, Treatment) By End-User (Hospitals, Specialty Care, Research Centers), and Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2032

MESSAGES FROM THE MANAGEMENT:

WHY MRFR?

MRFR OFFERINGS

TABLE OF CONTENTS

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS

1. EXECUTIVE’S HANDBOOK

1.1. The Top Performing Segments

1.2. Key Trends Summarized

1.3. Pricing Outlook

1.4. Strategic Insights

1.5. Who are the Key Players in the Market?

SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Report Segmentation & Scope

2.3. Regional & Country Level Coverage

2.4. Why you need this report?

3. RESEARCH METHODOLOGY

3.1. Research Process

3.2. Secondary Research

3.2.1. Data Mining & Condensation

3.2.2. Sources (Associations, Organizations, Magazines, Paid Databases)

3.3. Primary Research

3.3.1. Sample Size (Demand-Supply, Company TYPE, Designations, Region)

3.3.2. Sources

3.4. Factorial Analysis & Approach Setting

3.5. Estimation & Forecast Models

3.6. Pricing Baskets

3.7. Analyst Hours & Team

SECTION III: QUALITATIVE ANALYSIS

4. MARKET DYNAMICS

4.1. Introduction

4.2. Growth Parameters Mapped - Drivers

4.2.1. Growing aging population

4.2.2. Improved identification and diagnosis

4.2.3. increasing demand for technologically advanced treatment

4.3. What are the challenges faced by Industry Participants?

4.3.1. High cost of treatment

4.3.2. Threat to data security &strict regulatory Compliance

4.4. Opportunities

4.4.1. Collaboration with pharmaceutical companies and academic institutions

4.4.2. Opportunity 2

4.4.3. Opportunity 3

5. MARKET FACTOR ANALYSIS

5.1. Value chain Analysis

5.1.1. R&D and Designing

5.1.2. Manufacturing

5.1.3. Distribution & Sales

5.1.4. Post Sales Services

5.2. Porter’s Five Forces Model

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Impact on R&D

5.3.2. Impact on Pricing

5.3.3. Impact on Regions

SECTION IV: QUANTITATIVE ANALYSIS

6. GLOBAL DELIRIUM MARKET, BY TYPE (USD MILLION)

6.1. Introduction

6.2. Hyperactive

6.2.1. Global Delirium Market: Market Estimates & Forecast, By Hyperactive, 2019-2032

6.3. Hypoactive

6.3.1. Global Delirium Market: Market Estimates & Forecast, By Hypoactive, 2019-2032

6.4. Mixed

6.4.1. Global Delirium Market: Market Estimates & Forecast, By Mixed, 2019-2032

7. GLOBAL DELIRIUM MARKET, BY DIAGNOSIS AND TREATMENT (USD MILLION)

7.1. Introduction

7.2. Diagnosis

7.2.1. Global Delirium Market: Market Estimates & Forecast, By Diagnosis, 2019-2032

7.2.2. Laboratory Tests

7.2.3. Physical Examination

7.2.4. Imaging test

7.3. Treatment

7.3.1. Global Delirium Market: Market Estimates & Forecast, By Treatment, 2019-2032

7.3.2. Antipsychotics

7.3.3. Supportive care

8. GLOBAL DELIRIUM MARKET, BY END USER (USD MILLION)

8.1. Introduction

8.2. Hospitals

8.2.1. Global Delirium Market: Market Estimates & Forecast, By Hospitals, 2019-2032

8.3. Speciality Care

8.3.1. Global Delirium Market: Market Estimates & Forecast, By Speciality Care, 2019-2032

8.4. Research Centers

8.4.1. Global Delirium Market: Market Estimates & Forecast, By Research Centers, 2019-2032

9. GLOBAL DELIRIUM MARKET, BY REGION (USD MILLION)

9.1. Introduction

9.2. North America

9.2.1. North America Delirium Market: Market Estimates & Forecast, By Country, 2019-2032

9.2.2. North America Delirium Market: Market Estimates & Forecast, By Type, 2019-2032

9.2.3. North America Delirium Market: Market Estimates & Forecast, By Diagnosis and treatment, 2019-2032

9.2.4. North America Delirium Market: Market Estimates & Forecast, By End User, 2019-2032

9.2.5. US

9.2.6. US Delirium Market: Market Estimates & Forecast, By Type, 2019-2032

9.2.7. US Delirium Market: Market Estimates & Forecast, By Diagnosis and treatment, 2019-2032

9.2.7.1. US Delirium Market: Market Estimates & Forecast, By End User, 2019-2032

9.2.8. Canada

9.2.8.1. Canada Delirium Market: Market Estimates & Forecast, By Type, 2019-2032

9.2.8.2. Canada Delirium Market: Market Estimates & Forecast, By Diagnosis and treatment, 2019-2032

9.2.8.3. Canada Delirium Market: Market Estimates & Forecast, By End User, 2019-2032

9.2.9. Mexico

9.2.9.1. Mexico Delirium Market: Market Estimates & Forecast, By Type, 2019-2032

9.2.9.2. Mexico Delirium Market: Market Estimates & Forecast, By Diagnosis and treatment, 2019-2032

9.2.9.3. Mexico Delirium Market: Market Estimates & Forecast, By End User, 2019-2032

9.3. Europe

9.3.1.1. Europe Delirium Market: Market Estimates & Forecast, By Country, 2019-2032

9.3.1.2. Europe Delirium Market: Market Estimates & Forecast, By Type, 2019-2032

9.3.1.3. Europe Delirium Market: Market Estimates & Forecast, By Diagnosis and treatment, 2019-2032

9.3.1.4. Europe Delirium Market: Market Estimates & Forecast, By End User, 2019-2032

9.3.2. Germany

9.3.2.1. Germany Delirium Market: Market Estimates & Forecast, By Type, 2019-2032

9.3.2.2. Germany Delirium Market: Market Estimates & Forecast, By Diagnosis and treatment, 2019-2032

9.3.2.3. Germany Delirium Market: Market Estimates & Forecast, By End User, 2019-2032

9.3.3. France

9.3.3.1. France Delirium Market: Market Estimates & Forecast, By Type, 2019-2032

9.3.3.2. France Delirium Market: Market Estimates & Forecast, By Diagnosis and treatment, 2019-2032

9.3.3.3. France Delirium Market: Market Estimates & Forecast, By End User, 2019-2032

9.3.4. UK

9.3.4.1. UK Delirium Market: Market Estimates & Forecast, By Type, 2019-2032

9.3.4.2. UK Delirium Market: Market Estimates & Forecast, By Diagnosis and treatment, 2019-2032

9.3.4.3. UK Delirium Market: Market Estimates & Forecast, By End User, 2019-2032

9.3.5. Spain

9.3.5.1. Spain Delirium Market: Market Estimates & Forecast, By Type, 2019-2032

9.3.5.2. Spain Delirium Market: Market Estimates & Forecast, By Diagnosis and treatment, 2019-2032

9.3.5.3. Spain Delirium Market: Market Estimates & Forecast, By End User, 2019-2032

9.3.6. Italy

9.3.6.1. Italy Delirium Market: Market Estimates & Forecast, By Type, 2019-2032

9.3.6.2. Italy Delirium Market: Market Estimates & Forecast, By Diagnosis and treatment, 2019-2032

9.3.6.3. Italy Delirium Market: Market Estimates & Forecast, By End User, 2019-2032

9.3.7. Rest of Europe

9.3.7.1. Rest of Europe Delirium Market: Market Estimates & Forecast, By Type, 2019-2032

9.3.7.2. Rest of Europe Delirium Market: Market Estimates & Forecast, By Diagnosis and treatment, 2019-2032

9.3.7.3. Rest of Europe Delirium Market: Market Estimates & Forecast, By End User, 2019-2032

9.4. Asia-Pacific

9.4.1. Asia Pacific Delirium Market: Market Estimates & Forecast, By Country, 2019-2032

9.4.2. Asia Pacific Delirium Market: Market Estimates & Forecast, By Type, 2019-2032

9.4.3. Asia Pacific Delirium Market: Market Estimates & Forecast, By Diagnosis and treatment, 2019-2032

9.4.4. Asia Pacific Delirium Market: Market Estimates & Forecast, By End User, 2019-2032

9.4.5. China

9.4.5.1. China Delirium Market: Market Estimates & Forecast, By Type, 2019-2032

9.4.5.2. China Delirium Market: Market Estimates & Forecast, By Diagnosis and treatment, 2019-2032

9.4.5.3. China Delirium Market: Market Estimates & Forecast, By End User, 2019-2032

9.4.6. India

9.4.6.1. India Delirium Market: Market Estimates & Forecast, By Type, 2019-2032

9.4.6.2. India Delirium Market: Market Estimates & Forecast, By Diagnosis and treatment, 2019-2032

9.4.6.3. India Delirium Market: Market Estimates & Forecast, By End User, 2019-2032

9.4.7. Japan

9.4.7.1. Japan Delirium Market: Market Estimates & Forecast, By Type, 2019-2032

9.4.7.2. Japan Delirium Market: Market Estimates & Forecast, By Diagnosis and treatment, 2019-2032

9.4.7.3. Japan Delirium Market: Market Estimates & Forecast, By End User, 2019-2032

9.4.8. South Korea

9.4.8.1. South Korea Delirium Market: Market Estimates & Forecast, By Type, 2019-2032

9.4.8.2. South Korea Delirium Market: Market Estimates & Forecast, By Diagnosis and treatment, 2019-2032

9.4.8.3. South Korea Delirium Market: Market Estimates & Forecast, By End User, 2019-2032

9.4.9. Australia

9.4.9.1. Australia Delirium Market: Market Estimates & Forecast, By Type, 2019-2032

9.4.9.2. Australia Delirium Market: Market Estimates & Forecast, By Diagnosis and treatment, 2019-2032

9.4.9.3. Australia Delirium Market: Market Estimates & Forecast, By End User, 2019-2032

9.4.10. Rest of Asia-Pacific

9.4.10.1. Rest of Asia-Pacific Delirium Market: Market Estimates & Forecast, By Type, 2019-2032

9.4.10.2. Rest of Asia-Pacific Delirium Market: Market Estimates & Forecast, By Diagnosis and treatment, 2019-2032

9.4.10.3. Rest of Asia-Pacific Delirium Market: Market Estimates & Forecast, By End User, 2019-2032

9.5. Rest of the world

9.5.1. Middle East & Africa

9.5.1.1. Middle East and Africa Delirium Market: Market Estimates & Forecast, By Type, 2019-2032

9.5.1.2. Middle East and Africa Delirium Market: Market Estimates & Forecast, By Diagnosis and treatment, 2019-2032

9.5.1.3. Middle East and Africa Delirium Market: Market Estimates & Forecast, By End User, 2019-2032

9.5.2. Latin America

9.5.2.1. Latin America and Africa Delirium Market: Market Estimates & Forecast, By Type, 2019-2032

9.5.2.2. Latin America Delirium Market: Market Estimates & Forecast, By Diagnosis and treatment, 2019-2032

9.5.2.3. Latin America Delirium Market: Market Estimates & Forecast, By End User, 2019-2032

SECTION V: COMPETITIVE ANALYSIS

10. COMPETITIVE LANDSCAPE

10.1. Introduction

10.2. Competition Dashboard

10.3. Company Market Share Analysis, 2022-23 (%)

10.4. Who are the market disruptors & innovators?

10.5. What strategies are being adopted by market leaders?

10.6. Competitive Benchmarking

10.7. The Leading Player in terms of Number of Developments in the Global Delirium Market

10.8. List of Key Players, By Region

10.9. Public Players Stock Summary

10.10. Comparative Analysis: Key Players Financial

10.11. Key Developments & Growth Strategies

10.11.1. New Type Launch/Service Deployment

10.11.2. Merger & Acquisition

10.11.3. Joint Ventures

11. COMPANY PROFILES

11.1. Otsuka Pharmaceutical Co., Ltd

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Product Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Mylan N.V

11.2.1. Company Overview

11.2.2. Financial Overview

11.2.3. Product Offered

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Teva Pharmaceutical Industries Ltd

11.3.1. Company Overview

11.3.2. Financial Overview

11.3.3. Product Offered

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Zydus Group

11.4.1. Company Overview

11.4.2. Financial Overview

11.4.3. Product Offered

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Glenmark Pharmaceuticals Ltd

11.5.1. Company Overview

11.5.2. Financial Overview

11.5.3. Product Offered

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Pfizer

11.6.1. Company Overview

11.6.2. Financial Overview

11.6.3. Product Offered

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Mylan N.V

11.7.1. Company Overview

11.7.2. Financial Overview

11.7.3. Product Offered

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Teva Pharmaceutical Industries Ltd

11.8.1. Company Overview

11.8.2. Financial Overview

11.8.3. Product Offered

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Glenmark Pharmaceuticals Ltd

11.9.1. Company Overview

11.9.2. Financial Overview

11.9.3. Product Offered

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Novartis AG

11.10.1. Company Overview

11.10.2. Financial Overview

11.10.3. Product Offered

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

12. RECOMMENDATIONS & EXPERT INSIGHTS

12.1. What is the short-term vs long-term outlook for Delirium Market?

12.2. Who are the players to look out for?

12.3. What will the product mix look in coming years?

13. MRFR OFFERINGS & TEAM

13.1. Citations & Media

13.2. Our Regional Representatives

13.3. Related Reports

13.4. Our Domain Coverage

NOTE:

This table of content is tentative and subject to change as the research progresses.

 In section 11, only the top companies will be profiled. Each company will be profiled based on the Market Overview, Financials, Type Portfolio, Business Strategies, and Recent Developments parameters.

 In section 11, SWOT analysis will be provided for top 5 players

 Please note: The financial details of the company cannot be provided if the information is not available in the public domain and or from reliable sources.

LIST OF TABLES

TABLE 1. LIST OF ASSUMPTIONS

TABLE 2. GLOBAL DELIRIUM MARKET ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD MILLION)

TABLE 3. GLOBAL DELIRIUM MARKET FOR HYPERACTIVE MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION)